SDGR

Schrödinger, Inc.

Technology
Software - Application
$1.78B market cap

Forecast run · Oct 30, 2026Upside rank 1046 of 3,167

Model Signal

ForecastQ Daily Probabilities

35.8%

76.4%

35.6%

Analyst Consensus

Recommendation2.33/5 Buy

Last price$23.80

Price target$19.00

Implied move-20.2%

Analysts12

ForecastQ Portfolios

Technology Technology signal →

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.